FDA Inspection 1045855 — OPTILASA, S.L.
The FDA completed an inspection of OPTILASA, S.L. on February 1, 2018 in Madrid. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 1, 2018
- Fiscal Year
- 2018
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Madrid (Spain)